Current Availability of Adrenal Insufficiency Medications in the US

August 19th, 2024

• Hydrocortisone: no current shortage
• Solu-Cortef Autoinjector® : no current shortage
• Fludrocortisone acetate:
  • Teva recalled this product in July 2024  without providing a timeframe for when resupply is expected to occur.  The following products are currently available:

 
0.1 mg, 100 count bottle (NDC 0115-7033-01), marketed by Amneal
0.1 mg, 500 count bottle (NDC 0115-7033-01), marketed by Amneal
0.1 mg, 100 count bottle (NDC 42291-764-01), marketed by AvKARE
0.1 mg, 100 count bottle (NDC 72603-170-02), marketed by NorthstarRx
0.1 mg, 100 count bottle (NDC 70954-252-20), marketed by Novitium
0.1 mg, 100 count bottle (NDC 70954-252-30), marketed by Novitium
​

For information about medication shortage please visit:
www.accessdata.fda.gov/scripts/drugshortages/default.cfm
 
To report adverse effect of any medication please complete FDA Form 3500 B For Patients and Consumers which can be found here: 
www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program/medical-product-safety-information

​Mail or fax the completed form to:
MedWatch, Food and Drug Administration,
5600 Fishers Lane, Rockville, MD 20852;
FAX: 800-332-0178 (toll-free).